{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:08:34Z","timestamp":1782731314458,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02980-8","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:08:53Z","timestamp":1762164533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular diagnosis of viral hepatitis in the WHO African region: progress toward 2030 elimination goals"],"prefix":"10.1186","volume":"22","author":[{"given":"Patrick Okoti","family":"Aluora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2980_CR1","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis [Internet]. 2016 [cited 2025 Mar 15]. Available from: https:\/\/iris.who.int\/handle\/10665\/246177"},{"key":"2980_CR2","unstructured":"WHO, Hepatitis, B [Internet]. 2024 [cited 2021 Jun 24]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"2980_CR3","unstructured":"WHO, Hepatitis, C [Internet]. 2025 [cited 2023 Jan 27]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"2980_CR4","doi-asserted-by":"crossref","unstructured":"Valsamakis A. Molecular Testing in the Diagnosis and Management of Chronic Hepatitis B. Clin Microbiol Rev [Internet]. 2007 Jul [cited 2022 Nov 19];20(3):426. https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00009-07","DOI":"10.1128\/CMR.00009-07"},{"key":"2980_CR5","doi-asserted-by":"crossref","unstructured":"Wong GLH, Lemoine M. The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: Main changes and potential implications for the next major liver society clinical practice guidelines. J Hepatol [Internet]. 2025 May 1 [cited 2025 Sep 25];82(5):918\u201325. Available from: https:\/\/www.journal-of-hepatology.eu\/action\/showFullText?pii=S0168827824027557","DOI":"10.1016\/j.jhep.2024.12.004"},{"key":"2980_CR6","doi-asserted-by":"crossref","unstructured":"Lumley SF, Mokaya J, Maponga TG, Kramvis A, Dusheiko G, Irving W et al. Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field. Lancet Microbe [Internet]. 2025 Aug 1 [cited 2025 Sep 26];6(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40220768\/","DOI":"10.1016\/j.lanmic.2025.101076"},{"key":"2980_CR7","doi-asserted-by":"crossref","unstructured":"Lemoine M, Thursz MR. Battlefield against hepatitis B infection and HCC in Africa. J Hepatol [Internet]. 2017 Mar 1 [cited 2025 Sep 2];66(3):645\u201354. Available from: https:\/\/www.journal-of-hepatology.eu\/action\/showFullText?pii=S0168827816305785","DOI":"10.1016\/j.jhep.2016.10.013"},{"key":"2980_CR8","doi-asserted-by":"crossref","unstructured":"Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol [Internet]. 2017 Dec 1 [cited 2025 Sep 2];2(12):910\u20139. Available from: https:\/\/www.thelancet.com\/action\/showFullText?pii=S2468125317302492","DOI":"10.1016\/S2468-1253(17)30249-2"},{"key":"2980_CR9","doi-asserted-by":"crossref","unstructured":"O\u2019Hara GA, McNaughton AL, Maponga T, Jooste P, Ocama P, Chilengi R et al. Hepatitis B virus infection as a neglected tropical disease. PLoS Negl Trop Dis [Internet]. 2017 Oct 5 [cited 2025 Sep 2];11(10):e0005842. Available from: https:\/\/journals.plos.org\/plosntds\/article?id=10.1371\/journal.pntd.0005842","DOI":"10.1371\/journal.pntd.0005842"},{"key":"2980_CR10","doi-asserted-by":"crossref","unstructured":"Jemutai J, Downs L, Anderson M, Cohen C, Seeley J, Sultan B et al. Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families. Lancet Gastroenterol Hepatol [Internet]. 2025 Feb 1 [cited 2025 Sep 26];10(2):100\u20133. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39681128\/","DOI":"10.1016\/S2468-1253(24)00384-4"},{"key":"2980_CR11","unstructured":"Aluora OP. Genotypic Characterization of Hepatitis B Virus among Voluntary Blood Donors in Nairobi Regional Blood Transfusion Centre, Kenya [Internet]. [Nairobi]: Kenyatta University; 2021 [cited 2025 Sep 2]. Available from: http:\/\/ir-library.ku.ac.ke\/handle\/123456789\/23453"},{"key":"2980_CR12","doi-asserted-by":"crossref","unstructured":"Ochwoto M, Kimotho J, Oyugi J, Andonov A, Songok E, Osiowy C. Hepatitis B virus genotypes and unique recombinants circulating among outpatients in selected hospitals in Kenya. International Journal of Infectious Diseases [Internet]. 2016 Apr 1 [cited 2022 Nov 27];45:451\u20132. Available from: http:\/\/www.ijidonline.com\/article\/S1201971216309365\/fulltext","DOI":"10.1016\/j.ijid.2016.02.957"},{"key":"2980_CR13","doi-asserted-by":"crossref","unstructured":"Matlou MK, Gaelejwe LR, Musyoki AM, Rakgole JN, Selabe SG, Amponsah-Dacosta E. A novel hepatitis B virus recombinant genotype D4\/E identified in a South African population. Heliyon [Internet]. 2019 Apr 1 [cited 2024 Dec 2];5(4):e01477. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6453802\/","DOI":"10.1016\/j.heliyon.2019.e01477"},{"key":"2980_CR14","doi-asserted-by":"publisher","unstructured":"Aluora PO, Muturi MW, Gachara G. Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya. Virol J [Internet]. 2020;17(1):1\u20139. Available from: https:\/\/doi.org\/10.1186\/s12985-020-01447-2","DOI":"10.1186\/s12985-020-01447-2"},{"key":"2980_CR15","doi-asserted-by":"crossref","unstructured":"Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nature Protocols 2017 12:6 [Internet]. 2017 May 24 [cited 2025 Sep 2];12(6):1261\u201376. Available from: https:\/\/www.nature.com\/articles\/nprot.2017.066","DOI":"10.1038\/nprot.2017.066"},{"key":"2980_CR16","doi-asserted-by":"publisher","unstructured":"Saayman E, Hechter V, Kayuni N, Sonderup MW. A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa. Harm Reduct J [Internet]. 2023 Dec 1 [cited 2025 Sep 2];20(1):1\u20139. Available from: https:\/\/harmreductionjournal.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12954-023-00759-0","DOI":"10.1186\/s12954-023-00759-0"},{"key":"2980_CR17","doi-asserted-by":"crossref","unstructured":"Lumley SF, Kent C, Jennings D, Chai H, Airey G, Waddilove E et al. Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms. Sci Rep [Internet]. 2025 Dec 1 [cited 2025 Sep 26];15(1):5795. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11832747\/","DOI":"10.1038\/s41598-025-87721-1"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02980-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:08:59Z","timestamp":1762164539000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02980-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02980-8","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}